SPDR Health Care ETF (XLV) Stock
Key stats
- Market cap
- $40.14B
- Price / Earnings ratio
- 0.0x
- Volume
- Loading
- 52-week high
- $182.25
- 52-week low
- $141.97
Source: third-party data provider, as of October 31, 2026
Recent news

SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3
SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3
XLV

Make the Most of the Halloween Effect With These ETF Plays
Make the Most of the Halloween Effect With These ETF Plays
XLV

Banks and healthcare firms are outbidding tech for software talent, major recruiter says
Banks and healthcare firms are outbidding tech for software talent, major recruiter says
XLV

SLS Stock’s Big AML Trial Milestone Sparks A Selloff — What’s Fueling Retail’s ‘Extremely Bullish’ Bets?
SLS Stock’s Big AML Trial Milestone Sparks A Selloff — What’s Fueling Retail’s ‘Extremely Bullish’ Bets?
XLV
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 71.42
- MACD 12/26/9
- 3.23
- EMA 9 of MACD
- 2.56
- MACD histogram
- 0.67
- SMA 50
- $171.97
- Price above SMA 50
- EMA 50
- $172.00
- Price above EMA 50
- SMA 200
- $158.53
- Price above SMA 200
- EMA 200
- $161.18
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 29, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
Source: third-party data provider
Latest news

SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3
SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3
XLV

Make the Most of the Halloween Effect With These ETF Plays
Make the Most of the Halloween Effect With These ETF Plays
XLV

Banks and healthcare firms are outbidding tech for software talent, major recruiter says
Banks and healthcare firms are outbidding tech for software talent, major recruiter says
XLV

SLS Stock’s Big AML Trial Milestone Sparks A Selloff — What’s Fueling Retail’s ‘Extremely Bullish’ Bets?
SLS Stock’s Big AML Trial Milestone Sparks A Selloff — What’s Fueling Retail’s ‘Extremely Bullish’ Bets?
XLV

VKTX Stock Slides Overnight After Q3 Loss: CEO’s Obesity Drug Launch Timeline Frustrates Retail
VKTX Stock Slides Overnight After Q3 Loss: CEO’s Obesity Drug Launch Timeline Frustrates Retail
XLV

Why Did IOVA Stock Jump Over 10% After-Hours Today?
Why Did IOVA Stock Jump Over 10% After-Hours Today?
XLV

BSX Stock Crashes To 4-Year Lows: Boston Scientific Sees Q4 Sales Declining, CEO Remains Confident In ‘Long-Term Strategy’
BSX Stock Crashes To 4-Year Lows: Boston Scientific Sees Q4 Sales Declining, CEO Remains Confident In ‘Long-Term Strategy’
XLV

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
XLV

Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or State Street's XLV?
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or State Street's XLV?
XLV

Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines — The Week’s Biotech Watchlist
Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines — The Week’s Biotech Watchlist
XLV
News tone: automated (AI) classification of the article's content, not a price prediction.
About SPDR Health Care ETF
Health Care Select Sector SPDR Fund (XLV) tracks health care stocks from within the S&P 500 Index, weighted by market cap. The fund provides exposure to companies in pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology industries.
Fundamentals
Trading
Dividend
Source: third-party data provider, as of October 31, 2026
Technical indicators
- RSI 14
- 71.42
- MACD 12/26/9
- 3.23
- EMA 9 of MACD
- 2.56
- MACD histogram
- 0.67
- SMA 50
- $171.97
- Price above SMA 50
- EMA 50
- $172.00
- Price above EMA 50
- SMA 200
- $158.53
- Price above SMA 200
- EMA 200
- $161.18
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 29, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.9 | +8.8 | ||||||||||
| 2022 | -5.9 | -1.2 | +6.0 | -5.6 | +2.1 | -1.6 | +2.1 | -5.1 | -4.5 | +7.4 | +4.7 | -2.6 |
| 2023 | -1.6 | -5.1 | +2.0 | +2.0 | -4.8 | +3.2 | +1.9 | -0.2 | -3.6 | -3.1 | +5.2 | +3.5 |
| 2024 | +1.2 | +1.8 | +0.9 | -4.2 | +2.2 | +0.7 | +3.2 | +4.0 | -1.8 | -4.1 | -0.2 | -6.5 |
| 2025 | +6.7 | +1.0 | -2.4 | -2.0 | -2.9 | +1.6 | -4.6 | +4.8 | +1.2 | +0.5 | +9.1 | -0.3 |
| 2026 | -0.5 | +2.9 | -7.5 | -1.2 | +3.0 | +7.3 | +1.9 | +5.1 | -1.9 | +10.7 |
Corporate actions
Upcoming
No upcoming corporate actions for XLV




